Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 4, 2026 | $5.13 | +43.7% | $673.25M | +8.8% | $5.60 |
| Q1 FY26ended Mar 31, 2026 | Apr 29, 2026 | $4.84 | −0.4% | $657.51M | +1.6% | $5.34 |
| Q4 FY25ended Dec 31, 2025 | — | $5.50 | −8.8% | $639.34M | −0.1% | — |
| Q3 FY25ended Sep 30, 2025 | — | $4.46 | −10.8% | $624.90M | +3.1% | — |
| Q2 FY25ended Jun 30, 2025 | — | $3.57 | −23.2% | $618.80M | +3.8% | — |
| Q1 FY25ended Mar 31, 2025 | — | $4.86 | +14.6% | $646.94M | +9.8% | — |
| Q4 FY24ended Dec 31, 2024 | — | $6.03 | +2.2% | $639.99M | +9.2% | — |
| Q3 FY24ended Sep 30, 2024 | — | $5.00 | +1.4% | $606.18M | +7.4% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Chemed shares, not any token. As of Aug 4, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $4.65 | — | $595.88M | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $4.24 | — | $589.23M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $5.90 | — | $585.91M | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $4.93 | — | $564.53M | — | — |